Published Date: 13 May 2024
A better patient outcome and lower costs can be achieved through dose optimization.
Read Full NewsAs cancer survivorship rises, many people living with or beyond cancer face lasting physical and emotional challenges—particularly anxiety and depression, which affect about 30% of this population. Emotional distress is ...
A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong prognostic information, ...
The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration of tumors into major blood vessels that cause blood clots and multiorgan failure, a one-of-a-kind ...
1.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
2.
Survival is extended by a new treatment option for metastatic colorectal cancer.
3.
A radiotheranostic approach designed to combat aggressive cancers
4.
In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.
5.
Slowdown in progress found with cancer survival in England and Wales
1.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
2.
The Importance of Having a Quick and Effective Heparin Antidote
3.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
4.
Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care
5.
Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation